|
[1]
|
Marino, S., Sessa, E., Di Lorenzo, G., Lanzafame, P. and Scullica, G., et al. (2007) Quantitative analysis of pursuit ocular movements in Parkinson’s disease by using a video-based eye tracking system. European Neurology, 58, 193- 197. doi:10.1159/000107939
|
|
[2]
|
Marino, S., Lanzafame, P., Sessa, E., Bramanti, A. and Bramanti, P. (2010) The effect of L-Dopa administration on pursuit ocular movements in suspected Parkinson’s disease. Neurological Sciences, 31, 381-385.
doi:10.1007/s10072-009-0180-1
|
|
[3]
|
Cass, W.A., Grondin, R., Andersen, A.H., Zhang, Z., Hardy, P.A., Hussey-Andersen, L.K., Rayens, W.S., Gerhardt, G.A. and Gash, D.M. (2007) Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiology of Aging, 28, 258-271. doi:10.1016/j.neurobiolaging.2005.12.010
|
|
[4]
|
Schuff, N. (2009) Potential role of high-field MRI for studies in Parkin-son’s disease. Movement Disorders, 24, S684-S690. doi:10.1002/mds.22647
|
|
[5]
|
Karagulle Kendi, A.T., Lehericy, S., Luciana, M., Ugurbil, K. and Tuite, P. (2008) Altered diffusion in the frontal lobe in Parkinson’s disease. American Journal of Neuroradiology, 38, 501-505. doi:10.3174/ajnr.A0850
|
|
[6]
|
Hummel, T., Witt, M., Reichmann, H., Welge-Luessen, A. and Haehner, A. (2010) Immunohistochemical, volumetric, and functional neuroim-aging studies in patients with idiopathic Parkinson’s Disease. Journal of the Neuro-logical Sciences, 298, 119-122.
doi:10.1016/j.jns.2009.08.026
|
|
[7]
|
Wattendorf, E., Welge-Lüssen, A., Fiedler, K., Bilecen, D. and Wolfensberger, M., et al. (2009) Olfactory impair- ment predicts brain atrophy in Parkinson’s disease. The Journal of Neuroscience, 29, 15410-15413.
doi:10.1523/JNEUROSCI.1909-09.2009
|
|
[8]
|
Welge-Lüssen, A., Wattendorf, E., Schwerdtfeger, U., Fuhr, P., Bilecen, D., et al. (2009) Olfactory induced brain activity in Parkinson’s Disease relates to the expression of eventrelated potentials—An FMRI study. Neuroscience, 162, 537-543. doi:10.1016/j.neuroscience.2009.04.050
|
|
[9]
|
Lukhanina, E.P., Karaban, I.N., Chivliklii, M.A., Pil’kevich, N.A. and Berezetskaya, N.M. (2010) Electromyographic manifestations of hereditary signs of extrapiramidal insufficiency. Neuro-physiology, 42, 39-49.
doi:10.1007/s11062-010-9129-5
|
|
[10]
|
Robichaud, J. A., Pfann, K.D. and Leurgans, S., et al. (2009) Variability of EMG patterns: A potential neuro- physiological marker of Parkinson’s disease? Clinical Neurophysiology, 120, 390-397.
doi:10.1016/j.clinph.2008.10.015
|
|
[11]
|
Meigal, A.I., Rissanen, S., Tarvainen, M.P., Karjalainen, P.A., Iudina-Vassel, I.A., Airaksinen, O. and Kankaanp??, M. (2009) Novel parameters of surface EMG in patients with Parkinson’s disease and healthy young and old controls. Journal of Electromyography and Kinesiology, 19, e206-e213. doi:10.1016/j.jelekin.2008.02.008
|
|
[12]
|
Talebinejad, M., Chan, A.D. and Miri, A. (2010) Fatigue estimation using a novel multi-fractal detrended fluctuation analysis-based approach. Journal of Electromyography and Kinesiology, 20, 433-439.
doi:10.1016/j.jelekin.2009.06.002
|
|
[13]
|
Ikeda, A., Shibasaki, H., Kaji, R., Terada, K., Nagamine, T., Honda, M. and Kimura, J. (1997) Dissociation between contingent negative variation (CNV) and Bereits chaftspotential (BP) in patients with Par-kinsonism. Electroencephalography and Clinical Neurophysiology, 102, 142-151. doi:10.1016/S0921-884X(96)95067-5
|
|
[14]
|
Schmiedt, C., Meistrowitz, A., Schwendemann, G., Herr-mann, M. and Basar-Eroglu, C. (2005) Theta and alpha oscillations reflect differences in memory strategy and visual discrimination performance in patients with Parkinson’s disease. Neuroscience Letters, 388, 138-143.
doi:10.1016/j.neulet.2005.06.049
|
|
[15]
|
Dushanova, J., Philipova, D., Nikolova., G. (2009) Eventrelated synchroniza-tion/desynchronization during discrimination task conditions in patients with Parkinson’s disease. Cellular and Molecular Neurobiology, 29, 971-980.
doi:10.1007/s10571-009-9384-4
|
|
[16]
|
Dushanova, J., Philipova, D. and Nikolova, G. (2010) Beta and gamma frequency-range abnormalities in parkinsonian patients under cognitive sen-sorimotor task. Jour- nal of the Neurological Sciences, 293, 51-58.
doi:10.1016/j.jns.2010.03.008
|
|
[17]
|
Pavese, N. and Brooks, D.J. (2009) Imaging neurodegeneration in Parkinson’s Disease. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1792, 722-729.
doi:10.1016/j.bbadis.2008.10.003
|
|
[18]
|
Ferrer, I., Martinez, A., Blanco, R., Dalfó, E. and Carmona, M. (2011) Neuropathology of sporadic Parkinson’s disease before the appearance of Parkinsonism: Preclini- cal Parkinson’s disease. Journal of Neutral Transmission, 118, 821-839. doi:10.1007/s00702-010-0482-8
|
|
[19]
|
Wu, Y., Le, W. and Jankovic, J. (2011) Preclinical bio-markers of Parkinson’s disease. Archieves of Neurology, 68, 22-30. doi:10.1001/archneurol.2010.321
|
|
[20]
|
Jenkins, B.G., Sanchez-Pernaute, R., Brownell, A.L., Chen, Y.C. and Isacson, O. (2004) Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. The Journal of Neuroscience, 24, 9553-9560.
doi:10.1523/JNEUROSCI.1558-04.2004
|
|
[21]
|
Zhang, Z., An-dersen, A.H., Ai, Y., Loveland, A., Hardy, P.A., Gerhardt, G.A. and Gash, D.M. (2006) Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques. Neuroimage, 33, 636-643.
doi:10.1016/j.neuroimage.2006.07.004
|
|
[22]
|
Luan, L., Ding, F., Ai, Y., Andersen, A., Hardy, P., Forman, E., Gerhardt, G.A., Gash, D.M., Grondin, R. and Zhang, Z. (2008) Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys. Cell Trans- plant, 17, 417-425.
|
|
[23]
|
Rasmussen Jr., I. (2010) Psychopharmacological MRI. Acta Neuropsychiatrica, 22, 38-39.
doi:10.1111/j.1601-5215.2009.00432.x
|
|
[24]
|
Kim, Y., Kim, J., Ito, K., Lim, H.-S., Cheong, H.-K., Kim, J.Y., Shin, Y.C., Kim, K.S. and Moon, Y. (1999) Idio- pathic Parkinsonism with superimposed manganese exposure: Utility of positron emission tomography. Neuro- toxicology, 20, 249-252.
|
|
[25]
|
Guilarte, T.R., McGlothan, J.L., Degaonkar, M., Chen, M.K., Barker, P.B., Syversen, T. and Schneider, J.S. (2006) Evidence for cor-tical dysfunction and widespread man- ganese accumulation in the nonhuman primate brain following chronic manganese exposure: A 1H-MRS and MRI study. Toxicological Sciences, 94, 351-358.
doi:10.1093/toxsci/kfl106
|
|
[26]
|
Jiang, Y.M., Zheng, W., Long, L.L., Zhao, W.J., Li, X.R., Mo, X.A., Lu, J., Fu, X., Li, W., Liu, S., Long, Q., Huang, J. and Pira, E. (2007) Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: Search for biomarkers of manganese exposure. Neurotoxicology, 28, 126-135.
doi:10.1016/j.neuro.2006.08.005
|
|
[27]
|
Guilarte, T.R., Burton, N.C., McGlothan, J.L., Vernia, T., Zhou, Y., Alexander, M., Pham, L., Griswold, M., Wong, D.F., Syversen, T. and Schneider, J.S. (2008) Impairment of nigrostriatal dopamine neuro-transmission by manggnese is mediated by presynaptic mechanism(s): Implications to manganese-induced Parkin-sonism. Journal of Neurochemistry, 107, 1236-1247.
doi:10.1111/j.1471-4159.2008.05695.x
|
|
[28]
|
Chang, Y., Kim, Y., Woo, S.-T., Song, H.-J., Kim, S.H., Lee, H., Kwon, Y.J., Ahn, J.H., Park, S.-J., Chung, I.-S. and Jeong, K.S. (2009) High signal intensity on magnetic resonance imaging is a better pre-dictor of neurobehav- ioral performances than blood manganese in asympto- matic welders. Neuro Toxicology, 30, 555-563.
doi:10.1016/j.neuro.2009.04.002
|
|
[29]
|
Chang, Y., Woo, S.-T., Lee, J.-J., Song, H-J., Lee, H.J., Yoo, D.-S., Kim, S.H., Lee, H., Kwon, Y.J., Ahn, H.J., Ahn, J.H., Park, S.-J., Weon, Y.C., Chung, I.-S., Jeong, K.S. and Kim, Y. (2009) Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Neuro Toxicology, 30, 950-957.
doi:10.1016/j.neuro.2009.07.008
|
|
[30]
|
Chang, Y., Lee, J.J., Seo, J.H., Song, H.J., Kim, J.H., Bae, S.J., Ahn, J.H., Park, S.J., Jeong, K.S., Kwon. Y.J., Kim, S.H. and Kim, Y. (2010) Altered working memory process in the manganese-exposed brain. Neuroimage, 53, 1279- 1285. doi:10.1016/j.neuroimage.2010.07.001
|
|
[31]
|
Dydak, U., Jiang, Y.M., Long, L.L., Zhu, H., Chen, J., Li, W.M., Edden, R.A., Hu, S., Fu, X., Long, Z., Mo, X.A., Meier, D., Harezlak, J., Aschner, M., Murdoch, J.B. and Zheng, W. (2011) In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environmental Health Perspectives, 119, 219-224.
doi:10.1289/ehp.1002192
|
|
[32]
|
Kim, Y., Jeong, K.S., Song, H.-J., Lee, J.-J., Seo, J.-H., Kim, G.-C., Lee, H.J., Kim, H.J., Ahn, J.-H., Park, S.-J., Kim, S.H., Kwon, Y.J. and Chang, Y. (2011) Altered white matter microstructural integrity revealed by voxel- wise analysis of diffusion tensor imaging in welders with manganese exposure. Neuro Toxicology, 32, 100-109.
doi:10.1016/j.neuro.2010.11.004
|
|
[33]
|
Speziali, M. and Orvini, E. (2003) Metals distribution and regionalization in the brain. In: Zatta, P., Ed., Metal Ions and Neurodegenerative Disorders, World Scientific Publishing Co., New Jersey, 15-65.
doi:10.1142/9789812796691_0002
|
|
[34]
|
Qureshi, G.A., Qureshi, A.A., Memon, S.A. and Parvez, S.H. (2006) Impact of selenium, iron, copper and zinc in on/off Parkinson’s patients on L-dopa therapy. Journal of Neural Transmission, 71, 229-236.
doi:10.1007/978-3-211-33328-0_24
|
|
[35]
|
Tan, X., Luo, Y., Pan, J., Huang, B. and Wang P.Q. (2007) Serum Cu, Fe, Mn, and Zn levels and Parkinson’s disease. Parkinsonism & Related Disorders, 13, S134.
doi:10.1016/S1353-8020(08)70745-4
|
|
[36]
|
Speziali, M. and Di Casa, M. (2009) Copper, iron, zinc and other element concen-trations in cerebrospinal fluid of Parkinson’s disease pa-tients—Considerations on litera- ture data. Journal of Trace Elements and Electrolytes, 26, 171-176.
|
|
[37]
|
Ongkana, N., Tohno, S., Tohno, Y., Suwannahoy, P., Mahakkanukrauh, P., Azuma, C. and Minami, T. (2010) Age-related changes of ele-ments in the anterior commissures and the relationships among their elements. Biological Trace Element Research, 135, 86-97.
doi:10.1007/s12011-009-8496-5
|
|
[38]
|
Tohno, Y., Tohno, S., Ongkana, N., Suwannahoy, P., Azuma, C., Minami, T. and Mahakkanukrauh, P. (2010) Age-related changes of elements and relationships among elements in human hippocampus, dentate gyrus, and fornix. Biological Trace Element Research, 138, 42-52.
doi:10.1007/s12011-009-8605-5
|
|
[39]
|
Colman, K., Koerts, J., van Beilen, M., Leenders, K.L. and Bastiaanse, R. (2006) The role of cognitive mechanisms in sentence comprehension in dutch speaking Parkinson’s disease patients: Preliminary data. Brain and Language, 99, 109-110. doi:10.1016/j.bandl.2006.06.069
|
|
[40]
|
Boulenger, V., Mechtouff, L., Thobois, S., Broussolle, E., Jeannerod, M. and Nazir, T.A. (2008) Word processing in Parkinson’s disease is impaired for action verbs but not for concrete nouns. Neuropsychologia, 46, 743-756.
doi:10.1016/j.neuropsychologia.2007.10.007
|
|
[41]
|
Colman, K.S.F., Koerts, J., van Beilen, M., Leenders, K.L., Post, W. J. and Bastiaanse, R. (2009) The impact of executive functions on verb production in patients with Parkinson’s Disease. Cortex, 45, 930-942.
doi:10.1016/j.cortex.2008.12.010
|
|
[42]
|
McKinlay, A., Dalrym-ple-Alford, J.C., Grace, R.C. and Roger, D. (2009) The effect of attentional set-shifting, working memory, and processing speed on pragmatic language functioning in Parkinson’s Disease. European Journal of Cognitive Psychology, 21, 330-346.
doi:10.1080/09541440802281266
|
|
[43]
|
Kandori, A., Yokoe, M., Sakoda, S., Abe, K., Miyashita, T., Oe, H., Naritomi, H., Ogata, K. and Tsukada, K. (2004) Quantitative magnetic detection of finger movements in patients with Parkinson’s disease, Neuro-science Research, 49, 253-260. doi:10.1016/j.neures.2004.03.004
|
|
[44]
|
Endo, T., Okuno, R., Yokoe, M., Akazawa, K. and Sakoda, S. (2009) A novel method for systematic analysis of rigidity in Parkinson’s disease. Movement Disorders, 24, 2218-2224. doi:10.1002/mds.22752
|
|
[45]
|
Yokoe, M., Okuno, R., Hamasaki, T., Kurachi, Y., Akazawa, K. and Sakoda, S. (2009) Opening velocity, a novel pa- rameter, for finger tapping test in patients with Parkinson’s Disease, Parkinsonism & Related Disorders, 15, 440-444. doi:10.1016/j.parkreldis.2008.11.003
|
|
[46]
|
Yuceturk, A.V., Yilmaz, H., Egrilmez, M., Karaca, S. (2002) Voice analysis and videolaryngostroboscopy in patients with Parkinson’s disease. European Archives of Otorhinolaryngol, 259, 290-293.
|
|
[47]
|
Harel, B., Cannizzaro, M., Snyder, P.J. (2004) Variability in fundamental frequency during speech in prodromal and incipient Parkinson’s disease: A longitudinal case study. Brain Cognition, 56, 24-29.
doi:10.1016/j.bandc.2004.05.002
|
|
[48]
|
Sapir, S., Spielman, J., Ramig, L., Story, B., Fox, C. (2007) Effects of intensive voice treatment (LSVT?) on vowel articulation in dysarthric individuals with idio-pathic Parkinson’s disease: Acoustic and perceptual find- ings. Journal of Speech, Language, and Hearing Research, 50, 899-912. doi:10.1044/1092-4388(2007/064)
|
|
[49]
|
Yamamoto, Y., Struzik, Z.R., Soma, R., Ohashi, K. and Kwak, S. (2005) Noisy vestibular stimulation improves autonomic and motor responsiveness in central neuro- degenerative disorders. Annals of Neurology, 58, 175-181. doi:10.1002/ana.20574
|
|
[50]
|
Pan, W., Ohashi, K., Yamamoto, Y. and Kwak, S. (2007) Power-law temporal autocorrelation of activity reflects severity of parkinsonism. Movement Disorders, 22, 1308- 1313. doi:10.1002/mds.21527
|
|
[51]
|
Pan, W., Soma, R., Kwak, S. and Yamamoto, Y. (2008) Improvement of motor functions by noisy vestibular stimulation in central neurodegenerative disorders. Jour- nal of Neurology, 255, 1657-1661.
doi:10.1007/s00415-008-0950-3
|
|
[52]
|
Vaugoyeau, M., Viel, S., Assaiante, C., Amblard, B. and Azulay, J.P. (2007) Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease. Neuroscience, 146, 852-863.
doi:10.1016/j.neuroscience.2007.01.052
|
|
[53]
|
Hayashi, R., Aizawa, J., Nagase, H., Ohara, S. (2010) Lateral inclination of the trunk and falling frequency in Parkinson’s disease patients. Electromyography and Cli- nical Neurophysiology, 50, 195-202.
|
|
[54]
|
Johnson, A.M., Pollard, C.C., Vernon, P.A., Tomes, J.L. amd Jog, M.S. (2005) Memory perception and strategy use in Parlinson’s disease. Parkinsonism & Related Dis- orders , 1, 111-115. doi:10.1016/j.parkreldis.2004.06.005
|
|
[55]
|
Yogev, G., Giladi, N., Peretz, C., Springer, S., Simon, E.S. and Hausdorff, J.M. (2005). Dual tasking, gait rhyth- micity, and Parkinson’s disease: Which aspects of gait are attention demanding? European Journal of Neuroscience, 22, 1248-1256. doi:10.1111/j.1460-9568.2005.04298.x
|
|
[56]
|
Goebel, S., Mehdorn, H.M. and Leplow, B. (2010) Stra- tegy instruction in Parkinson’s disease: Influence on cog- nitive performance. Neuropsychologia, 48, 574-580.
doi:10.1016/j.neuropsychologia.2009.10.020
|
|
[57]
|
Aarsland, D., Br?nnick, K. and Fladby, T. (2011) Mild cognitive impairment in Parkinson’s disease. Current Neu- rology and Neuroscience Reports, 11, 371-378.
doi:10.1007/s11910-011-0203-1
|
|
[58]
|
Patel, S., Lorincz, K., Hughes, R., Huggins, N., Growdon, J., Standaert, D. (2009) Monitoring motor fluctuations in patients with Parkinson’s disease using wearable sensors. IEEE Transactions on Information Technology in Bio- medicine, 13, 864-873. doi:10.1109/TITB.2009.2033471
|
|
[59]
|
Tindall, L.R. and Huebner, R.A. (2009) The Impact of an application of telerehabilitation technology on caregiver burden. International Journal of Telerehabilitation, 1, 3-8.
doi:10.5195/ijt.2009.5559
|
|
[60]
|
Papapetropoulos, S., Heather, K., Scanlo, B.K., Guevara, A., Singer, C. and Levin, B. (2010) Objective quantification of neuromotor symptoms in Parkinson?s disease: Imple- mentation of a portable, computerized measurement tool. Parkinson’s Disease, 760196.
|
|
[61]
|
Patel, S., Buckley, T., Rednic, R., McClure, D., Shih, L., Tarsy, D., et al. (2010) A web-based system for home monitoring of patients with Parkinson’s disease using wearable sensors. IEEE Transactions on Biomedical Engi- neering, 58, 831-836.
|
|
[62]
|
Westin, J., Dougherty, M., Nyholm, D. and Groth, T. (2010) A home environment test battery for status assessment in patients with advanced Parkinson’s disease. Computer Methods and Programs in Biomedicine, 98, 27-35.
doi:10.1016/j.cmpb.2009.08.001
|
|
[63]
|
Devos, H., Vandenberghe, W., Nieuwboer, A., Tant, M., Baten, G. and De Weerdt, W. (2007) Predictors of fitness to drive in people with Parkinson’s disease. Neurology, 69,1434-1441. doi:10.1212/01.wnl.0000277640.58685.fc
|
|
[64]
|
Cordell, R., Lee, H.C., Granger, A., Vieira, B. and Lee, A.H. (2008) Driving assessment in Parkinson’s disease: A novel predictor of performance. Movement Disorders, 23, 1217-1222. doi:10.1002/mds.21762
|
|
[65]
|
Uc, E.Y., Rizzo, M., Johnson, J.E., Dastrup, E., Anderson, S.W. and Dawson, J. (2009) Road safety in drivers with Parkinson’s Disease. Neurology, 73, 2112-2119.
doi:10.1212/WNL.0b013e3181c67b77
|
|
[66]
|
Uitti, R.J. (2009) Parkinson’s Disease and issues related to driving. Parkinsonism & Related Disorders, 15, S122- S125.
|
|
[67]
|
Gobbi, L., Oliveira-Ferreira, M.D., Caetano, M.J., Lirani- Silva, E., Barbieri, F., Stella, F. and Gobbi, S. (2009) Ex- ercise programs improve mobility and balance in people with Parkinson’s disease. Parkinsonism & Related Dis- orders, 15, S49-S52.
doi:10.1016/S1353-8020(09)70780-1
|
|
[68]
|
Sage, M. and Almeida, Q. (2009) Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson’s disease. Movement Disorders, 24, 1132-1138. doi:10.1002/mds.22469
|
|
[69]
|
Tanaka, K., Quadros, A.C., Jr., Santos, R., Stella, F., Gobbi, L. and Gobbi, S. (2009) Benefits of physical exer- cise on executive functions in older people with Parkinson’s Disease. Brain and Cognition, 69, 435-441.
doi:10.1016/j.bandc.2008.09.008
|
|
[70]
|
Hackney, M. and Earhart, G. (2010) Effects of dance on gait and balance in Parkinson’s disease: A comparison of partnered and nonpartnered dance movement. Neurore- habilitation and Neural Repair, 24, 384-392.
|
|
[71]
|
Sage, M. and Almeida, Q. (2010) A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson’s Disease. Movement Disorders, 25, 64-69.
|
|
[72]
|
Beijer, L., Rietveld, T., Hoskam, V., Geurts, A. and de Swart, B. (2010) Evaluating the feasibility and the potential efficacy of e-learning-based speech therapy for speech training in dysarthric patients with Parkinson’s Disease: A case study. Telemedicine and E-Health, 16, 732-738.
|
|
[73]
|
Ellis, T., de Goede, C.J., Feldman, R.G., Wolters, E.C., Kwakkel, G. and Wagenaar, R.C. (2005) Efficacy of a physical therapy program in patients with Parkinson’s di- sease: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 86, 626-632.
doi:10.1016/j.apmr.2004.08.008
|
|
[74]
|
Lun, V., Pullan, N., Labelle, N., Adams, C. and Sucho- wersky, O. (2005) Comparison of the effects of a self- supervised home exercise program with a physiotherapist supervised exercise program on the motor symptoms of Parkinson’s disease. Movement Disorders, 20, 971-975.
doi:10.1002/mds.20475
|
|
[75]
|
Keus, S., Bloem, B.R., Hendriks, E., Bredero-Cohen, A. and Munneke, M. (2007) Evidence-based analysis of phy- sical therapy in Parkinson’s disease with recommen- dations for practice and research. Movement Disorders, 22, 451-460. doi:10.1002/mds.21244
|
|
[76]
|
Brichetto,G., Pelosin, E., Marchese, R. and Abbruzzese, G. (2006) Evaluation of physical therapy in parkinsonian patients with freezing of gait: A pilot study. Clinical Reha- bilitation, 20, 31-35. doi:10.1191/0269215506cr913oa
|
|
[77]
|
Schmitz-Hübsch, T., Pyfer, D., Kielwein, K., Fimmers, R., Klockgether, T. and Wüllner, U. (2006) Qigong exercise for the symptoms of Parkinson’s Disease: A randomized, controlled pilot study. Movement Disorders, 21, 543-548.
doi:10.1002/mds.20705
|
|
[78]
|
Herman, T., Giladi, N., Gruendlinger, L. and Hausdorff, J.M. (2007) Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson’s disease: A pilot study. Archives of Physical Medicine and Rehabilitation, 88, 1154-1158.
doi:10.1016/j.apmr.2007.05.015
|
|
[79]
|
J?bges, E., Spittler-Schneiders, H., Renner, C. and Hum- melsheim, H. (2007) Clinical relevance of rehabilitation programs for patients with idiopathic Parkinson syn- drome II: Symptom-specific therapeutic approaches. Par- kinsonism & Related Disorders, 13, 203-213.
doi:10.1016/j.parkreldis.2006.07.018
|
|
[80]
|
Takahashi, Y., Osamu, N. and Komeda, T. (2008) De- velopment of a sit-to-stand assistance system. Lecture Notes in Computer Science, 5105, 1277-1284.
doi:10.1007/978-3-540-70540-6_191
|
|
[81]
|
Costa, J., Valls-Sole, J., Valldeoriola, F., Pech, C. and Rumia, J. (2006) Single subthalamic nucleus deep brain stimuli inhibit the blink reflex in Parkinson’s disease patients. Brain, 129, 1758-1767.
doi:10.1093/brain/awl143
|
|
[82]
|
Costa, J., Valls-Sole, J., Valldeoriola, F., Rumia, J. and Tolosa, E. (2007) Motor responses of muscles supplied by cranial nerves to subthalamic nucleus deep brain stimuli. Brain, 130, 245-255. doi:10.1093/brain/awl336
|
|
[83]
|
Valls-Solé, J., Compta, Y., Costa, J., Valldeoriola, F. and Rumià, J. (2008) Human central nervous system circuits examined through the electrodes implanted for deep brain stimulation. Clinical Neurophysiology,119, 1219-1231.
doi:10.1016/j.clinph.2007.12.020
|
|
[84]
|
Alessandro, S., Ceravolo, R., Brusa, L., Pierantozzi, M., Costa, A., Galati, S., Placidi, F., Romigi, A., Iani, C., Marzetti, F. and Peppe, A. (2010) Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains. Journal of the Neurological Sciences, 289, 44-48.
doi:10.1016/j.jns.2009.08.017
|
|
[85]
|
Kim, H.J., Jeon, B.S., Paek, S.H., Lee, J.Y., Kim, H.J., Kim, C.K. and Kim, D.G. (2010) Bilateral subthalamic deep brain stimulation in Parkinson disease patients with se- vere tremor. Neurosurgery, 67, 626-632.
doi:10.1227/01.NEU.0000374850.98949.D4
|
|
[86]
|
Lee, J.Y., Kim, J.W., Lee, J.Y., Lim, Y.H., Kim, C., Kim, D.G., Jeon, B.S. and Paek, S.H. (2010) Is MRI a reliable tool to locate the electrode after deep brain stimulation sur- gery? Comparison study of CT and MRI for the localization of electrodes after DBS. Acta Neurochi- rurgica, 152, 2029-2036. doi:10.1007/s00701-010-0779-2
|
|
[87]
|
Paek, S.H., Han, J.H., Lee, J.Y., Kim, C., Jeon, B.S. and Kim, D.G. (2008) Electrode position determined by fused images of preoperative and postoperative magnetic reso- nance imaging and surgical outcome after subthalamic nucleus deep brain stimulation. Neurosurgery, 63, 925- 937. doi:10.1227/01.NEU.0000334045.43940.FB
|
|
[88]
|
Cho, Z.H., Min, H.K., Oh, S.H., Han, J.Y., Park, C.W., Chi, J.G., Kim, Y.B., Paek, S.H., Lozano, A.M. and Lee, K.H. (2010) Direct visualization of deep brain stimulation targets in Parkinson’s disease with the use of 7-tesla magnetic resonance imaging. Journal of Neurosurgery, 113, 639-647. doi:10.3171/2010.3.JNS091385
|
|
[89]
|
Paek, S.H., Kim, J.W., Lim, Y.H., Kim, M.R., Kim, D.G. and Jeon, B.S. (2010) Data management system in a movement disorder center: Technical report. Stereotactic and Functional Neurosurgery, 88, 216-223.
doi:10.1159/000314356
|
|
[90]
|
Paek, S.H., Kim, H.J., Yoon, J.Y., Heo, J.H., Kim, C.Y., Kim, M.R., Lim, Y.H., Kim, K.R., Han, J.H., Kim, D.G. and Jeon, B.S. (2011) Fusion image-based programming after subthalamic nucleus deep brain stimulation. World Neurosurgery ,75, 517-524.
doi:10.1016/j.wneu.2010.12.003
|
|
[91]
|
Tani, N., Saitoh, Y., Kishima, H., Oshino, S., Hatazawa, J., Hashikawa, K. and Yoshimine, T. (2007) Motor cortex stimulation for levodopa-resistant akinesia: Case report. Movement Disorders, 22, 1645-1649.
doi:10.1002/mds.21593
|
|
[92]
|
Saitoh, Y. and Hosomi, K. (2009) From localization to surgical implantation. In: Canavero, S., Ed., Textbook of Therapeutic Cortical Stimulation, Nova Science Publi- shers, Inc., New York.
|
|
[93]
|
Kryzak, T.J., Sperling, J.W., Schleck, C.D. and Cofield, R. H. (2009) Total shoulder arthroplasty in patients with Parkinson’s Disease. Journal of Shoulder and Elbow Surgery, 18, 96-99. doi:10.1016/j.jse.2008.07.010
|
|
[94]
|
Kryzak, T.J., Sperling, J.W., Schleck, C.D. and Cofield, R.H. (2010) Hemiarthroplasty for proximal humerus fractures in patients with Parkinson’s Disease. Clinical Orthopaedics and Related Research, 468, 1817-1821.
doi:10.1007/s11999-010-1353-1
|
|
[95]
|
Greffard, S., Verny, M., Bonnet, A.M., Seilhean, D., Hauw, J.J. and Duyckaerts, C. (2010) A stable proportion of lewy body bearing neurons in the substantia nigra suggests a model in which the lewy body causes neuronal death. Neurobiology Aging, 31, 99-103.
doi:10.1016/j.neurobiolaging.2008.03.015
|
|
[96]
|
Li, J.Y., Englund, E., Widner, H., Rehncrona, S., Bj?rklund, A., Lindvall, O. and Brundin, P. (2010) Characterization of lewy body pathology in 12- and 16-year-old intra- striatal mesencephalic grafts surviving in a patient with Parkinson’s disease. Movement Disorders, 25, 1091-1096.
doi:10.1002/mds.23012
|
|
[97]
|
Stocchi, F., Rascol, O., Kieburtz, K., Poewe, W., Jankovic, J., Tolosa, E., Barone, P., Lang, A.E. and Olanow, C.W. (2010) Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study. Annals of Neurology, 68, 18-27.
doi:10.1002/ana.22060
|
|
[98]
|
Hauser, R.A, Schapira, A.H., Rascol, O., Barone, P., Mizuno, Y., Salin, L., Haaksma, M., Juhel, N. and Poewe, W. (2010) Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkin- son’s Disease. Movement Disorders, 25, 2542-2549.
doi:10.1002/mds.23317
|
|
[99]
|
Marks, W.J., Bartus, R.T., Siffert, J., Davis, C.S., Lozano, A., Boulis, N., Vitek, J., Stacy, M., Turner, D., Verhagen, L., Bakay, R., Watts, R., Guthrie, B., Jankovic, J., Simpson, R., Tagliati, M., Alterman, R., Stern, M., Baltuch, G., Starr, P.A., Larson, P.S., Ostrem, J.L., Nutt, J., Kieburtz, K., Kordower, J.H. and Olanow, C.W. (2010) Gene deli- very of AAV2-neurturin for Parkinson’s disease: A dou- ble-blind, randomised, controlled trial. The Lancet Neuro- logy, 9, 1164-1172. doi:10.1016/S1474-4422(1
|
|
[100]
|
Almeida, Q.J., Frank, J.S., Roy, E.A., Patla, A.E., and Jog, M.S. (2007) Dopaminergic modulation of timing control and variability in the gait of Parkinson’s disease. Move- ment Disorders, 22, 1735-1742. doi:10.1002/mds.21603
|
|
[101]
|
Almeida, Q.J. and Lebold, C.A. (2010) Freezing of gait in Parkinson’s disease: A perceptual cause for a motor im- pairment? Journal of Neurology, Neurosurgery & Psy- chiatry, 81, 513-518. doi:10.1136/jnnp.2008.160580
|
|
[102]
|
Brown, M.J. and Almeida, Q.J. (2011) Evaluating dopa- minergic system contributions to cued pattern switching during bimanual coordination. European Journal of Neuro- science, 34, 632-640.
doi:10.1111/j.1460-9568.2011.07773.x
|
|
[103]
|
Serra, J.A., Domínguez, R.O., Marschoff, E.R., Guareschi E.M., Famulari, A.L. and Boveris, A. (2009) Systemic oxidative stress associated with the neurological diseases of aging. Neurochemical Research, 34, 2122-2132.
doi:10.1007/s11064-009-9997-5
|
|
[104]
|
Farooqui, T. and Farooqui, A. (2011) Lipid-mediated oxi- dative stress and inflammation in the pathogenesis of Parkinson’s disease. Parkinson’s Disease, 247467
|
|
[105]
|
Kaur, D., Lee, D., Ragapolan, S. and Andersen, J.K. (2009) Glutathione depletion in immortalized midbrain- derived dopaminergic neurons results in increases in the labile iron pool: Implications for Parkinson’s disease. Free Radical Biology & Medicine, 46, 593-598.
doi:10.1016/j.freeradbiomed.2008.11.012
|
|
[106]
|
Lee, D.W., Kaur, D., Chinta, S.J., Rajagopalan, S. and Andersen, J.K. (2009) A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glu- taredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: Implications for Parkinson’s disease. Antioxid & Redox Signaling, 11, 2083-2094.
doi:10.1089/ars.2009.2489
|
|
[107]
|
Gomez, F.J., Aguirre, P., Gonzalez-Billault, C. and Nú?ez, M.T. (2011) Iron mediates neuritic tree collapse in mesen- cephalic neurons treated with 1-methyl-4-phenylpyridi- nium (MPP+). Journal of Neural Transmission, 118, 421- 431. doi:10.1007/s00702-010-0489-1
|
|
[108]
|
Pelizzoni, I., Macco, R., Morini, M.F., Zacchetti, D., Grohovaz, F. and Codazzi, F. (2011). Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell, 10, 172- 183. doi:10.1111/j.1474-9726.2010.00652.x
|
|
[109]
|
Kohbata, S. and Shimokawa, K. (1993) Circulating anti- body to Nocardia in the serum of patients with Parkinson’s disease. Advances in Neurology, 60, 355-357.
|
|
[110]
|
Kohbata, S., Tamura, T. and Hayashi, R. (1998) Accu- mulation of acid-fast lipochrome bodies in glial cells of the midbrain nigral lesion in Parkinson’s Disease. Clini- cal and Diagnositic Laboratory Immunology, 5, 888-893.
|
|
[111]
|
Crichton, R.R., Dexter, D.T. and Ward, R.J. (2008) Mole- cular-based neurodegenerative diseases: From molecular mechanisms to therapeutic strategies Coordination Che- mistry Reviews, 252, 1189-1199.
doi:10.1016/j.ccr.2007.10.019
|
|
[112]
|
Marinova-Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J.B., Medhurst, A.D. and Dexter, D.T. (2009) Relationship between microglial activation and dopami- nergic neuronal loss in the substantia nigra: A time course study in a 6-hydroxydopamine model of Parkinson’s di- sease. Journal of Neurochemistry, 110, 966-975.
doi:10.1111/j.1471-4159.2009.06189.x
|
|
[113]
|
Dexter, D.T., Statton, S.A., Whitmore, C., Freinbichler, W., Weinberger, P., Tipton, K.T., Della Corte, L., Ward, R.J. and Crichton, R.R. (2011) Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after periphereal administration. Journal of Neural Transmission, 118, 223-231.
doi:10.1007/s00702-010-0531-3
|
|
[114]
|
Ward, R.J., Lallemand, F., De Witte, P., Crichton, R.R., Piette, J., Della Corte, L., Hemmings, K., Page, M., Taylor, D. and Dexter, D.T. (2011) Anti-inflammatory actions of taurine analogues in phagocytic cells. Bioche- mical Pharmacology, 81, 743-751.
doi:10.1016/j.bcp.2010.12.030
|
|
[115]
|
Cheung, Z.H. and Ip, N.Y. (2009) The emerging role of autophagy in Parkinson’s disease. Molecular Brain, 2, 29.
doi:10.1186/1756-6606-2-29
|
|
[116]
|
Lai, K.O. and Ip, N.Y. (2009) Recent advances in under- standing the roles of Cdk5 in synaptic plasticity. Bio- chimica et Biophysica Acta, 1792, 741-745.
doi:10.1016/j.bbadis.2009.05.001
|
|
[117]
|
Gorbatyuk, O.S., Li, S., Sullivan, L.F., Chen, W., Kon- drikova, G., Manfredsson, F.P., Mandel, R.J. and Mu- zyczka, N. (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Pro-ceeding of the National Academy of Sciences USA, 105, 763-768.
|
|
[118]
|
Nakamura, K., Nemani, V.M., Azarbal, F., Skibinski, G., Levy, J.M., Egami, K., Munishkina, L., Zhang, J., Gard- ner, B., Wakabayashi, J., Sesaki, H., Cheng, Y., Finkbe- iner, S., Nussbaum, R.L., Masliah, E. and Edwards, R.H. (2011) Direct membrane association drives mitochondrial fission by the Parkinson Disease-associated protein {al- pha}-synuclein. The Journal of Biological Chemistry, 286, 20710-20726. doi:10.1074/jbc.M110.213538
|
|
[119]
|
Muntane, G., Dalfo, E., Martinez, A. and Ferrer, I. (2008) Phosphorylation of tau and alpha-synuclein in synaptic- enriched fractions of the frontal cortex in Alzheimer’s disease and in Parkinson’s disease and related alpha- synucleinopathies. Neuroscience, 152, 913-923.
doi:10.1016/j.neuroscience.2008.01.030
|
|
[120]
|
Chambraud, B., Sardin, E., Giustiniani, J., Dounane, O., Schumacher, M., Goedert, M. and Baulieu, E.E. (2010). A role for FKBP52 in Tau protein function. Proceeding of the National Academy of Sciences USA, 107, 2658-2663.
doi:10.1073/pnas.0914957107
|
|
[121]
|
Fusco, D., Vargiolu, M., Vidone, M., Mariani, E., Pennisi, L.F., Bonora, E., Capellari, S., Dirnberger, D., Baumeister, R., Martinelli, P. and Romeo, G. (2010) The RET51/ FKBP52 complex and its involvement in Parkinson dis- ease. Human Molecular Genetics, 19, 2804-2816.
doi:10.1093/hmg/ddq181
|
|
[122]
|
Schuster, S., Nadjar, A., Guo, J.T., Li, Q., Ittrich, C., Hengerer, B. and Bezard, E. (2008) The 3-hydroxy-3- methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of LDOPA-induced abnormal involuntary move- ments in experimental Parkinson’s disease. Journal of Neuroscience, 28, 4311-4316.
doi:10.1523/JNEUROSCI.4720-07.2008
|
|
[123]
|
Salvatore, M.F., Pruett, B.S., Spann, S.L. and Dempsey, C. (2009) Aging reveals a role for nigral tyrosine hydroxy- lase ser31 phosphorylation in locomotor activity genera- tion. PLoS ONE, 4, e8466.
doi:10.1371/journal.pone.0008466
|
|
[124]
|
Pruett, B.S. and Sal-vatore, M.F. (2010) GFRα-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways. Journal of Neuro-chemistry, 115, 707-715.
doi:10.1111/j.1471-4159.2010.06963.x
|
|
[125]
|
Todd, A.M. and Staveley, B.E. (2008) Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila mo- del of Parkinson's disease. Genome, 51, 1040-1046.
doi:10.1139/G08-085
|
|
[126]
|
Botella, J.A., Bayersdorfer, F. and Schneuwly, S. (2008) Superoxide dismutase overexpression protects dopaminer- gic neurons in a Drosophila model of Par-kinson’s disease. Neurobiology of Disease, 30, 65-73.
doi:10.1016/j.nbd.2007.11.013
|
|
[127]
|
Deng, H., Dodson, M.W., Huang, H. and Guo, M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proceedings of the National Academy Science USA, 105, 14503-14508. doi:10.1073/pnas.0803998105
|
|
[128]
|
Liu, Z., Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., Ren, Q., Jiao, Y., Sawa, A., Moran, T., Ross, C.A., Montell, C. and Smith, W.W. (2008) A Dro-sophila model for LRRK2- linked parkinsonism. Proceedings of the National Acad- emy Science USA, 105, 2693-2398.
|
|
[129]
|
Trinh, K., Moore, K., Wes, P.D., Muchowski, P.J., Dey, J., Andrews, L. and Pallanck, L.J. (2008) Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson’s disease. Journal of Neuro- science, 28, 465-472.
doi:10.1523/JNEUROSCI.4778-07.2008
|
|
[130]
|
Tanner, C.M. (2003) Is the cause of Parkinson’s disease environmental or hereditary? Evidence from twin studies. Advances in Neurology, 91, 133-142.
|
|
[131]
|
Dick, F.D., et al. (2007) Environmental risk factors for Parkinson’s disease and Parkinsonism: The Geoparkinson study. Occupational and Environmental Medicine, 64, 666- 672. doi:10.1136/oem.2006.027003
|
|
[132]
|
Crotty, S., Fitzgerald, P., Tuohy, E., Harris, D.M., Fisher, A., Mandel, A., Bolton, A.E., Sullivan, A.M. and Nolan, Y. (2008) Neuroprotective effects of novel phosphatidyl- glycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson’s disease. European Journal of Neu- roscience, 27, 294-300.
doi:10.1111/j.1460-9568.2007.06018.x
|
|
[133]
|
Gasser, T. (2009) Molecular pathogenesis of Parkinson disease: Insights from genetic studies. Expert Reviews in Molecular Medicine, 11, e22.
doi:10.1017/S1462399409001148
|
|
[134]
|
Lees, A.J., Hardy, J. and Revesz, T. (2009) Parkinson’s disease. Lancet, 373, 2055-2066.
doi:10.1016/S0140-6736(09)60492-X
|
|
[135]
|
Borah, A. and Mohanakumar, K.P. (2010). L-DOPA- induced 6-hydroxydopamine production in the striata of rodents is sen-sitive to the degree of denervation. Neuro- chemistry Interna-tional, 56, 357-362.
doi:10.1016/j.neuint.2009.11.008
|
|
[136]
|
Banegas, I., Prieto, I., Alba, F., Vives, F., Araque, A., Segarra, A.B., Durán, R., de Gasparo, M. and Ramírez, M. (2005) Angiotensinase activity is asymmetrically distrib- uted in the amygdala, hippocampus and prefrontal cortex of the rat. Behavioural Brain Research, 156, 321-326.
doi:10.1016/j.bbr.2004.06.002
|
|
[137]
|
Banegas, I., Prieto, I., Vives, F., Alba, F., de Gasparo, M., Duran, R., Luna, J. de D., Segarra, A.B., Hermoso, F. and Ramírez, M. (2009) Asymmetrical response of aminopep- tidase A and nitric oxide in plasma of normotensive and hypertensive rats with experimental hemiparkinsonism. Neuropharmacology, 56, 573-579.
doi:10.1016/j.neuropharm.2008.10.011
|
|
[138]
|
Banegas, I., Prieto, I., Vives, F., Alba, F., de Gasparo, M., Duran, R., Segarra, A.B. and Ramírez, M. (2010) Later- alized response of oxytocinase activity in the medial pre- frontal cortex of a unilateral rat model of Parkinson’s disease. Behavioural Brain Research, 213, 328-331.
doi:10.1016/j.bbr.2010.05.030
|
|
[139]
|
Gotthardt, K., Weyand, M., Kortholt, A., van Haastert, P.J. and Wittinghofer, A. (2008) Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. The EMBO Journal, 27, 2239-2249. doi:10.1038/emboj.2008.150
|
|
[140]
|
van Egmond, W.N., Kortholt, A., Plak, K., Bosgraaf, L., Bosgraaf, S., Keizer-Gunnink, I. and van Haastert, P.J. (2008) Intramolecular activation mechanism of the Dic- tyostelium LRRK2 homolog Roco protein GbpC. The Journal of Biological Chemistry, 283, 30412-30420.
doi:10.1074/jbc.M804265200
|
|
[141]
|
van Egmond, W.N. and van Haastert, P.J. (2010) Charac- terization of the Roco protein family in Dictyostelium discoideum. Eukaryot Cell, 9, 751-761.
doi:10.1128/EC.00366-09
|
|
[142]
|
Araki, T., van Egmond, W.N., van Haastert, P.J. and Wil- liams, J.G. (2010) Dual regulation of a Dictyostelium STAT by cGMP and Ca2+ signalling. Journal of Cell Sci- ence, 123, 837-841. doi:10.1242/jcs.064436
|
|
[143]
|
Ibá?ez-Sandoval, O., Carrillo-Reid, L., Galarraga, E., Tapia, D., Mendoza, E., Gomora, J.C., Aceves, J. and Bargas, J. (2007) Bursting in substantia nigra pars reticu- lata neurons in vitro: Possible relevance for Parkinson disease. Journal of Neurophysiology, 98, 2311-2323.
doi:10.1152/jn.00620.2007
|
|
[144]
|
Carrillo-Reid, L., Tecuapetla, F., Tapia, D., Hernandez- Cruz, A., Galarraga, E., Drucker-Colin, R. and Bargas, J. (2008) Encoding network states by striatal cell assemblies. Journal of Neurophysiology, 99, 1435-1450.
doi:10.1152/jn.01131.2007
|
|
[145]
|
Li, X., Ouyang, G., Usami, A., Ikegaya, Y. and Sik, A. (2010) Scale-free topology of the CA3 hippocampal net- work: A novel method to analyze functional neuronal as- semblies. Biophysical Journal, 98, 1733-1741.
doi:10.1016/j.bpj.2010.01.013
|
|
[146]
|
Jaidar, O., Carrillo-Reid, L., Hernandez, A., Drucker- Colin, R., Bargas, J. and Hernan-dez-Cruz, A. (2010) Dy- namics of the Parkinsonian striatal microcircuit: Entrain- ment into a dominant network state. Journal of Neuro- science, 30, 11326-11336.
doi:10.1523/JNEUROSCI.1380-10.2010
|
|
[147]
|
Goldberg, M.S., Pisani, A., Haburcak, M., Vortherms, T.A., Kitada, T., Costa, C., Tong, Y., Martella, G., Tscherter, A., Martins, A., Bernardi, G., Roth, B.L., Pothos, E.N., Calabresi, P. and Shen, J. (2005) Nigrostriatal dopa- minergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron, 45, 489-496. doi:10.1016/j.neuron.2005.01.041
|
|
[148]
|
Gautier, C.A., Kitada, T. and Shen, J. (2008) Loss of PINK1 causes mitochondrial functional defects and in- creased sensitivity to oxidative stress. Proceedings of the National Academy Science USA, 105, 11364-11369.
doi:10.1073/pnas.0802076105
|
|
[149]
|
Healy, D.G., et al. and International LRRK2 Consortium (2008) Phenotype, genotype, and worldwide genetic pene- trance of LRRK2-associated Par-kinson’s disease: A case- control study. The Lancet Neurology, 7, 583-590.
doi:10.1016/S1474-4422(08)70117-0
|
|
[150]
|
Lin, X., et al. (2009) Leucine-rich repeat kinase 2 regu- lates the progression of neuropathology induced by Park- inson’s-disease-related mutant alpha-synuclein. Neuron, 64, 807-827. doi:10.1016/j.neuron.2009.11.006
|
|
[151]
|
Li, Y., et al. (2009) Mutant LRRK2(R1441G) BAC trans- genic mice recapitulate cardinal features of Parkinson’s disease. Nature Neuroscience, 12, 826-828.
doi:10.1038/nn.2349
|
|
[152]
|
Simon-Sanchez, J., et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nature Genetics, 41, 1308-1312. doi:10.1038/ng.487
|
|
[153]
|
Venderova, K., et al. (2009) Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson’s disease. Human Mo- lecular Genetics, 18, 4390-4404.
doi:10.1093/hmg/ddp394
|
|
[154]
|
Natale, G., Kastsiushenka, O., Fulceri, F., Ruggieri, S., Paparelli, A. and Fornai, F. (2010) MPTP-induced Park- insonism extends to a subclass of TH positive neurons in the gut. Brain Research, 1355, 195-206.
doi:10.1016/j.brainres.2010.07.076
|
|
[155]
|
Hamza, T.H., et al. (2010) Common genetic variation in the HLA region is associ-ated with late-onset sporadic Parkinson’s disease. Nature Ge-netics, 42, 781-785.
doi:10.1038/ng.642
|
|
[156]
|
Li, X., Patel, J.C., Wang, J., Avshalumov, M.V., Nichol- son, C., Buxbaum, J.D., Elder, G.A., Rice, M.E. and Yue, Z. (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpres-sion in mice is eliminated by familial Parkinson's disease muta-tion G2019S. Journal of Neuroscience, 30, 1788-1797.
doi:10.1523/JNEUROSCI.5604-09.2010
|
|
[157]
|
Im, S.A., Choi, H.S., Hwang, B.Y., Lee, M.K. and Lee, C.K. (2009) Augmenta-tion of immune responses by oral administration of Gynostemma pentaphyllum ethanol ex- tract. Korean Journal of Pharmacognosy, 40, 35-40.
|
|
[158]
|
Choi, H.S., Park, M.S., Kim, S.H., Hwang, B.Y., Lee, C.K. and Lee, M.K. (2010) Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkin- son’s disease. Molecules, 15, 2814-2824.
doi:10.3390/molecules15042814
|
|
[159]
|
Sinicropi, M.S., Leone, F., Rovito, N. and Genchi, G. (2010) Behaviour of ace-tyl-L-carnitine injections (Ni- cetile? fiale) with different drugs used for combined ther- apy. Advances in Therapy, 27, 547-554.
doi:10.1007/s12325-010-0055-0
|
|
[160]
|
Zhang, H.Y., Jia, H.Q., Liu, J.H., Ao, N., Yan, B., Shen, W.L., Wang, X.M., Li, X., Luo, C. and Liu, J.K. (2010) Combined R-alpha-lipoic acid and ace-tyl-L-carnitine ex- erts efficient preventative effects in a cellular model of Parkinson’s disease. Journal of Cellular and Mo-lecular Medicine, 14, 215-225.
doi:10.1111/j.1582-4934.2008.00390.x
|
|
[161]
|
Massart, R., Guilloux, J. P., Mignon, V., Sokoloff, P. and Diaz, J. (2009) Striatal Gpr88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. European Journal of Neuroscience, 30, 397-414.
doi:10.1111/j.1460-9568.2009.06842.x
|
|
[162]
|
Jimenez-Del-Rio, M. and Velez-Pardo, C. (2006) Insulin- like growth factor-1 prevents Aβ[25-35]/(H2O2)-induced apoptosis in lymphocytes by reciprocal NF-κB activation and p53 inhibition via PI3K-dependent pathway. Growth Factors, 24, 67-78. doi:10.1080/08977190500361788
|
|
[163]
|
Jimenez-Del-Rio, M., Daza-Restrepo, A. and Velez-Pardo, C. (2008) The cannabinoid CP55, 940 prolongs survival and improves locomotor activity in Drosophila melano- gaster against paraquat: Implications in Parkinson’s dis- ease. Neuroscience Research, 61, 404-411.
doi:10.1016/j.neures.2008.04.011
|
|
[164]
|
Avila-Gomez, I.C., Velez-Pardo, C. and Jimenez-Del-Rio, M. (2010) Effects of insulin-like growth factor-1 on ro- tenone-induced apoptosis in lymphocyte cells. Basic & Clinical Pharmacology & Toxicology, 106, 53-61.
|
|
[165]
|
Velez-Pardo, C., Jimenez-Del-Rio, M., Lores-Arnaiz, S. and Bustamante, J. (2010) Protective effects of the syn- thetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. Neurochemical Re- search, 35, 1323-1332. doi:10.1007/s11064-010-0188-1
|
|
[166]
|
Long-Smith, C.M., Sul-livan, A.M. and Nolan, Y.M. (2009) The influence of microglia on the pathogenesis of Park- inson’s disease. Progress in Neu-robiology, 89, 277-287.
doi:10.1016/j.pneurobio.2009.08.001
|
|
[167]
|
Long-Smith, C.M., Collins, L., Toulouse, A., Sullivan, A.M. and Nolan, Y.M. (2010) Interleukin-1beta contrib- utes to dopaminergic neuronal death induced by lipopo- lysaccharide-stimulated rat glia in vitro. Journal of Neuro- immunology, 226, 20-26.
doi:10.1016/j.jneuroim.2010.05.030
|
|
[168]
|
Antonelli, T., Tomasini, M.C., Fuxe, K., Agnati, L.F., Tanganelli, S. and Fer-raro, L. (2007) Receptor-receptor interactions as studied with microdialysis. Focus on NTR/ D2 interactions in the basal gan-glia. Journal of Neural Transmission, 114, 105-113.
doi:10.1007/s00702-006-0558-7
|
|
[169]
|
Ferraro, L., Tomasini, M.C., Beggiato, S., Guerrini, R., Salvadori, S., Fuxe, K., Calzà, L., Tanganelli, S. and An- tonelli, T. (2009) Emerging evidence for neurotensin re- ceptor 1 antagonists as novel pharmaceutics in neurode- generative disorders. Mini Reviews in Medical Chemistry, 9, 1429-1438. doi:10.2174/138955709789957495
|
|
[170]
|
Niknejad, H., Peirovi, H., Jorjani, M., Ahmadiani, A., Ghanavi, J. and Seifalian, A.M. (2008) Properties of the amniotic membrane for potential use in tissue engineering. European Cells and Materials, 15, 88-99.
|
|
[171]
|
Niknejad, H., Peirovi, H., Ahmadiani, A., Ghanavi, J. and Jorjani, M. (2010) Differentiation factors that influence neuronal markers expression in vitro from human amniotic epi-thelial cells. European Cells and Materials, 19, 22-29.
|
|
[172]
|
Bartels, A.L., Willemsen, A.T., Kortekaas, R., de Jong, B.M., de Vries, R., de Klerk, O., van Oostrom, J.C., Portman, A. And Leenders, K.L. (2008) Decreased blood- brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA. Journal of Neural Transmission, 115, 1001-1009.
doi:10.1007/s00702-008-0030-y
|
|
[173]
|
Thornton, E., Tran, T.T. and Vink, R. (2010) A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death. Neuroscience Letters, 481, 64-67.
doi:10.1016/j.neulet.2010.06.057
|
|
[174]
|
Alachkar, A., Brotchie, J.M. and Jones, O. (2006) Alpha2-adrenoceptor-mediated mod-ulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata. Neuroscience Letters, 395, 138-142.
doi:10.1016/j.neulet.2005.10.069
|
|
[175]
|
Alachkar, A., Brotchie, J.M. and Jones, O. (2010) Bind- ing of dopamine and 3-methoxytyramine as l-DOPA me- tabolites to human al-pha(2)-adrenergic and dopaminergic receptors. Neuroscience Research, 67, 245-249.
doi:10.1016/j.neures.2010.03.008
|
|
[176]
|
Alachkar, A., Brotchie, J.M. and Jones, O. (2010) Loco- motor response to L-DOPA in reserpine treated rats fol- lowing central inhibition of aromatic L-amino acid de- carboxylase: Further evidence for non-dopaminergic ac- tions of L-DOPA and its metabolites. Neuroscience Re- search, 68, 44-50. doi:10.1016/j.neures.2010.06.003
|
|
[177]
|
Takasaki, S. (2009) Mitochondrial haplogroups associated with Japanese cente-narians, Alzheimer’s patients, Parkinson’s patients, type 2 dia-betic patients and healthy non-obese young males. Journal of Genetics and Genom- ics, 36, 425-434. doi:10.1016/S1673-8527(08)60132-0
|
|
[178]
|
Suzuki, M., Kurita, A. and Hashimoto, M. (2006) Im- paired myocardial 123Imetaiodobenzylguanidine uptake in Lewy body disease: Comparison between dementia with Lewy bodies and Parkin-son’s Disease. Journal of the Neurological Sciences, 240, 15-19.
doi:10.1016/j.jns.2005.08.011
|
|
[179]
|
Suzuki, M., Urashima, M. and Oka., H. (2007) Cardiac sympathetic denervation in bradykinesia-dominant Park- inson’s disease. Neuroreport, 18, 1867-1870.
doi:10.1097/WNR.0b013e3282f1ab33
|